Equity News Results

  • Dow Rises 2% to Start the Week

    By Anna Hirtenstein and Alexander Osipovich. U.S. stocks climbed Monday as investors weighed the rise in coronavirus infections and the likelihood of future lockdowns with hopes for more stimulus from central banks. The Dow gained 480 points, or 1.9%, in afternoon trading, recovering some of the ground it lost after sliding 3.3% last week.

  • Dow Rises 2% to Start the Week

    By Anna Hirtenstein, Alexander Osipovich and Joanne Chiu. U.S. stocks climbed Monday as investors weighed the rise in coronavirus infections and the likelihood of future lockdowns with hopes for more stimulus from central banks. The Dow gained 485 points, or 1.9%, in early afternoon trading, recovering some of the ground it lost after sliding 3.3% last week.

  • U.S. Stocks Climb to Start the Week

    By Anna Hirtenstein, Alexander Osipovich and Joanne Chiu. U.S. stocks climbed Monday as investors weighed the rise in coronavirus infections and the likelihood of future lockdowns with hopes for more stimulus from central banks. The Dow gained 465 points, or 1.9%, in early afternoon trading, recovering some of the ground it lost after sliding 3.3% last week.

  • U.S. Stocks Climb to Start the Week

    By Anna Hirtenstein, Alexander Osipovich and Joanne Chiu. U.S. stocks climbed Monday as investors weighed the rise in coronavirus infections and the likelihood of future lockdowns with hopes for more stimulus from central banks. The Dow gained 440 points, or 1.8%, in morning trading, recovering some of the ground it lost after sliding 3.3% last week.

  • U.S. Stocks Tick Up to Start the Week

    The Dow Jones Industrial Average climbed Monday as investors weighed the rise in coronavirus infections with the likelihood of future lockdowns and the continuation of easy monetary policy. The Dow gained 0.8% in morning trading. The gauge of blue-chip stocks shed 3.3% last week, putting it on track for a retreat this month.

  • U.S. Stocks Tick Up to Start the Week

    Share benchmarks climbed on Monday, as investors weighed the rise in coronavirus infections with the likelihood of future lockdowns and the continuation of easy monetary policy. The Dow Jones Industrial Average gained 0.8% in early New York trading. The gauge of blue-chip stocks shed 3.3% last week, putting it on track for a retreat this month.

  • Global Stocks Struggle to Bounce Back

    European stocks and U.S. stock futures wavered at the start of the week, as investors worried that any new wave of coronavirus infections could hold back a global economic recovery. The pan-continental Stoxx Europe 600 was up 0.3%, with stocks in the region led higher by Germany's Dax index. In Asia, Hong Kong's Hang Seng Index fell about 1.2%, while the Shanghai Composite pulled back 0.6%.

  • Global Markets Follow U.S. Lower

    International markets started the week under pressure, as investors worried about the risk a new wave of coronavirus infections will hold back a global economic recovery. As of Monday afternoon Hong Kong time, Japan's Nikkei 225, South Korea's Kospi Composite and Australia's S&P/ASX 200 all declined around 2%. Hong Kong's Hang Seng Index fell about 1.6%, while the Shanghai Composite pulled back 0.7%.

  • U.S. Stocks Fall More Than 2%, End Week Lower

    The Dow Jones Industrial Average dropped more than 700 points and limped to a weekly loss as daily coronavirus infections rapidly increased, fanning worries about a slowdown in the economy's reopening. The spreading cases around the country dampened the optimism that had buoyed markets in recent weeks. The U.S. marked a daily record of nearly 40,000 new infections on Thursday.

  • U.S. Stocks Fall More Than 2%, End Week Lower

    The Dow Jones Industrial Average dropped more than 700 points and limped home to a weekly loss as daily coronavirus infections increased rapidly, fanning worries about a slowdown in the economy's reopening. The S&P 500 fell 2.4% as of the 4 p.m. The Dow lost 730 points, or 2.8%.

Search News

Filter Results

Publication Date
Topic
Provider

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.